Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial

被引：32
|
作者：
Tokumasu, M. [1 ]
Murata, C. [2 ]
Shimada, A. [3 ]
Ohki, K. [2 ]
Hayashi, Y. [2 ]
Saito, A. M. [4 ]
Fujimoto, J. [5 ]
Horibe, K. [4 ]
Nagao, M. [6 ]
Itoh, H. [6 ]
Kamikubo, Y. [6 ]
Nakayama, H. [7 ]
Kinoshita, A. [8 ]
Tomizawa, D. [9 ]
Taga, T. [10 ]
Tawa, A. [11 ]
Tanaka, S. [12 ]
Heike, T. [1 ]
Adachi, S. [6 ]
机构：
[1] Kyoto Univ, Dept Pediat, Kyoto, Japan
[2] Gunma Childrens Med Ctr, Dept Hematol Oncol, Shibukawa, Japan
[3] Okayama Univ, Dept Pediat, Okayama, Japan
[4] Natl Hosp Org, Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan
[5] Natl Ctr Child Hlth & Dev, Clin Res Ctr, Tokyo, Japan
[6] Kyoto Univ, Human Hlth Sci, Kyoto, Japan
[7] Natl Hosp Org, Fukuoka Higashi Med Ctr, Dept Pediat, Koga, Japan
[8] St Marianna Univ, Sch Med, Dept Pediat, Kawasaki, Kanagawa, Japan
[9] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Div Leukemia & Lymphoma, Tokyo, Japan
[10] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga 52021, Japan
[11] Natl Hosp Org, Osaka Med Ctr, Dept Pediat, Osaka, Japan
[12] Kyoto Univ, Dept Pharmacoepidemiol, Kyoto, Japan
来源：
LEUKEMIA | 2015年 / 29卷 / 12期
关键词：
ACUTE MYELOID-LEUKEMIA; GENETIC LESIONS; RELAPSE; FLT3; RAS;
D O I：
10.1038/leu.2015.121
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2438 / 2441
页数：5
相关论文
共 50 条
  • [41] Prognostic impact of minimal residual disease (MRD) assessment in acute myeloid leukemia (AML) with mutated NPM1: Results of the AML study group (AMLSG)
    Kroenke, J.
    Schlenk, R. F.
    Jensen, K-O
    Eiwen, K.
    Onken, S.
    Habdank, M.
    Spaeth, D.
    Krauter, J.
    Ganser, A.
    Goehring, G.
    Schlegelberger, B.
    Luebbert, M.
    Wattad, M.
    Kindler, T.
    Salih, H. R.
    Mergenthaler, H-G
    Goetze, K.
    Doehner, H.
    Doehner, K.
    ONKOLOGIE, 2010, 33 : 136 - 136
  • [42] Risk-Stratified Therapy and the Intensive Use of Cytarabine Improves the Outcome in Childhood Acute Myeloid Leukemia: The AML99 Trial From the Japanese Childhood AML Cooperative Study Group
    Tsukimoto, Ichiro
    Tawa, Akio
    Horibe, Keizo
    Tabuchi, Ken
    Kigasawa, Hisato
    Tsuchida, Masahiro
    Yabe, Hiromasa
    Nakayama, Hideki
    Kudo, Kazuko
    Kobayashi, Ryoji
    Hamamoto, Kazuko
    Imaizumi, Masue
    Morimoto, Akira
    Tsuchiya, Shigeru
    Hanada, Ryoji
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (24) : 4007 - 4013
  • [43] WT1 mutation in pediatric patients with acute myeloid leukemia: a report from the Japanese Childhood AML Cooperative Study Group
    Hirozumi Sano
    Akira Shimada
    Ken Tabuchi
    Tomohiko Taki
    Chisato Murata
    Myoung-ja Park
    Kentaro Ohki
    Manabu Sotomatsu
    Souichi Adachi
    Akio Tawa
    Ryoji Kobayashi
    Keizo Horibe
    Masahiro Tsuchida
    Ryoji Hanada
    Ichiro Tsukimoto
    Yasuhide Hayashi
    International Journal of Hematology, 2013, 98 : 437 - 445
  • [44] WT1 mutation in pediatric patients with acute myeloid leukemia: a report from the Japanese Childhood AML Cooperative Study Group
    Sano, Hirozumi
    Shimada, Akira
    Tabuchi, Ken
    Taki, Tomohiko
    Murata, Chisato
    Park, Myoung-ja
    Ohki, Kentaro
    Sotomatsu, Manabu
    Adachi, Souichi
    Tawa, Akio
    Kobayashi, Ryoji
    Horibe, Keizo
    Tsuchida, Masahiro
    Hanada, Ryoji
    Tsukimoto, Ichiro
    Hayashi, Yasuhide
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (04) : 437 - 445
  • [45] Core Binding Factor Acute Myeloid Leukemia in Pediatric Patients of the AIEOP AML 2002/01 Trial: Screening and Prognostic Impact of CKIT Mutations
    Manara, Elena
    Bisio, Valeria
    Beqiri, Valzerda
    Rondelli, Roberto
    Menna, Giuseppe
    Micalizzi, Concetta
    Santoro, Nicola
    Locatelli, Franco
    Basso, Giuseppe
    Pigazzi, Martina
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2014, 36 (04) : 323 - 323
  • [46] Treatment of acute myeloid leukemia patients aged more than 75 years: Results of the E-AML-01 trial of the Japanese Elderly Leukemia and Lymphoma Study Group (JELLSG)
    Mori, Mayumi
    Ohta, Masatsugu
    Miyata, Akira
    Higashihara, Masaaki
    Oshimi, Kazuo
    Kimura, Hideo
    Yagasaki, Fumiharu
    Sunami, Kazutaka
    LEUKEMIA & LYMPHOMA, 2006, 47 (10) : 2062 - 2069
  • [47] Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group
    Gaidzik, Verena Ingeborg
    Schlenk, Richard Friedrich
    Moschny, Simone
    Becker, Annegret
    Bullinger, Lars
    Corbacioglu, Andrea
    Krauter, Juergen
    Schlegelberger, Brigitte
    Ganser, Arnold
    Doehner, Hartmut
    Doehner, Konstanze
    BLOOD, 2009, 113 (19) : 4505 - 4511
  • [48] PROGNOSTIC IMPACT OF WT1 MUTATIONS IN THE CONTEXT OF OTHER MOLECULAR MARKERS IN CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA (AML): A STUDY OF THE GERMAN-AUSTRIAN AML STUDY GROUP (AMLSG)
    Gaidzik, V. I.
    Moschny, S.
    Becker, A.
    Groner, S.
    Spaeth, D.
    Krauter, J.
    Schlegelberger, B.
    Ganser, A.
    Doehner, H.
    Schlenk, R. F.
    Doehner, K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 375 - 375
  • [49] High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial (vol 172, pg 581, 2020)
    Shiba, N.
    Ohki, K.
    Kobayashi, T.
    Hara, Y.
    Yamato, G.
    Tanoshima, R.
    Ichikawa, H.
    Tomizawa, D.
    Park, M. -J
    Shimada, A.
    Sotomatsu, M.
    Arakawa, H.
    Horibe, K.
    Adachi, S.
    Taga, T.
    Tawa, A.
    Hayashi, Y.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (01) : 199 - 199
  • [50] High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group
    Shimada, Akira
    Taki, Tomohiko
    Koga, Daisuke
    Tabuchi, Ken
    Tawa, Akio
    Hanada, Ryoji
    Tsuchida, Masahiro
    Horibe, Keizo
    Tsukimoto, Ichiro
    Adachi, Souichi
    Kojima, Seiji
    Hayashi, Yasuhide
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (04) : 469 - 476
12345